Can BAH's $39 Billion Backlog Offset Its Q1 Revenue Decline?

Booz Allen Hamilton’s BAH first-quarter fiscal 2027 performance presented a contrast: revenues weakened, but profitability, earnings and cash generation improved. Revenues fell 4.2% year over year to $2.8 billion from $2.92 billion, reflecting the bifurcated market conditions highlighted by the company. The decline raises questions about near-term sales momentum, but the rest of the quarter points to resilient execution.

Profit Growth Eases Top-Line Concerns

Adjusted EBITDA increased 7.4% to $334 million, while the adjusted EBITDA margin expanded 130 basis points to 11.9%. Adjusted diluted earnings per share advanced 22.3% to $1.81, supported by stronger profitability, a lower tax rate, a reduced share count and unrealized investment gains. Free cash flow surged 171.9% to $261 million, aided by solid collections. BAH therefore converted a smaller revenue base into stronger profits and cash flow.

Backlog Supports Revenue Visibility

The central factor is BAH’s backlog. Total backlog increased 3% year over year to $39 billion, while funded backlog climbed 15%. A quarterly book-to-bill ratio of 1.5 times shows that awards outpaced recognized revenues. The trailing-12-month ratio of 1.1 times also remained above one, suggesting demand has not disappeared despite the quarterly contraction. Converting those awards into revenues will determine whether the decline proves temporary.

How Leidos and SAIC Fit Into the Picture

Leidos LDOS and Science Applications International Corporation SAIC provide relevant reference points within government services. For investors comparing BAH with Leidos and SAIC, backlog conversion, contract execution and cash generation are key considerations. However, the slide provides no peer-specific figures, making direct performance conclusions about either company unsupported.

The Takeaway

BAH’s revenue decline warrants attention, but stronger margins, earnings, cash flow and bookings soften the concern. Its $39 billion backlog is the clearest indication that the company retains a sizeable base of future work.

BAH carries a Zacks Rank #3 (Hold) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Research Chief Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research